Waters (WAT)
(Delayed Data from NYSE)
$386.69 USD
-0.48 (-0.12%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $386.53 -0.16 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$386.69 USD
-0.48 (-0.12%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $386.53 -0.16 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth B Momentum C VGM
Zacks News
3 Stocks to Watch on Rising Demand for Scientific Instruments
by Aniruddha Ganguly
The Zacks Instruments - Scientific industry participants like Mettler-Toledo (MTD), PerkinElmer (PKI) and Waters Corporation (WAT) are gaining from strong life science, pharmaceutical and academic end-market demand as well as rising healthcare spending.
Waters (WAT) BioAccord System to Expand Portfolio Offerings
by Zacks Equity Research
Waters (WAT) introduces Waters BioAccord System with ACQUITY Premier for seamless monitoring of attributes of biotherapeutics.
Waters (WAT) Up 5.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Waters (WAT) have what it takes to be a top stock pick for momentum investors? Let's find out.
Can Waters (WAT) Run Higher on Rising Earnings Estimates?
by Zacks Equity Research
Waters (WAT) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Himax (HIMX) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Himax's (HIMX) Q2 earnings are likely to have gained from strength witnessed in its small- and medium-sized display driver IC business.
Zillow Group (ZG) to Report Q2 Earnings: What's in Store?
by Zacks Equity Research
Zillow Group's (ZG) Q2 performance is likely to reflect strength in IMT and Mortgage segments.
Waters (WAT) Q2 Earnings & Revenues Beat Estimates, Rise Y/Y
by Zacks Equity Research
Waters' (WAT) second-quarter results reflect gains from strong momentum across pharmaceutical, industrial, and governmental and academic markets.
Diodes (DIOD) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Diodes' (DIOD) second-quarter results are likely to benefit from robust adoption of its products in the automotive, industrial, communications and computing end-markets.
What's in Store for Kulicke and Soffa (KLIC) in Q3 Earnings?
by Zacks Equity Research
Kulicke and Soffa's (KLIC) third-quarter fiscal 2021 results are expected to benefit from strong demand for its solutions in the semiconductor, automotive and LED end-markets.
Fastly (FSLY) Set to Report Q2 Earnings: What to Expect?
by Zacks Equity Research
Fastly's (FSLY) second-quarter 2021 results are expected to benefit from higher bandwidth usage and an expanding clientele.
Waters (WAT) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Waters' (WAT) second-quarter 2021 results are likely to reflect strength across liquid chromatography instruments and mass spectrometers.
Waters (WAT) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Waters (WAT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mettler-Toledo (MTD) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Mettler-Toledo's (MTD) second-quarter results are likely to reflect benefits of strong momentum across laboratory, industrial and retail businesses.
What's in Store for United Microelectronics (UMC) Q2 Earnings?
by Zacks Equity Research
United Microelectronics' (UMC) second-quarter results are expected to reflect the impacts of strength across 28 nm and 22 nm shipments.
What's in the Cards for TE Connectivity's (TEL) Q3 Earnings?
by Zacks Equity Research
TE Connectivity's (TEL) fiscal third-quarter results are expected to reflect solid momentum across the Transportation and Communication segments amid coronavirus-led headwinds.
PayPal (PYPL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
PayPal's (PYPL) second-quarter results are likely to reflect growing user engagement, solid P2P momentum and portfolio strength.
Why Waters (WAT) is a Top Momentum Stock for the Long-Term
by Zacks Equity Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Alphabet (GOOGL) to Report Q2 Earnings: What's in the Cards?
by Zacks Equity Research
Alphabet's (GOOGL) second-quarter results are likely to reflect strength across search, ad and cloud businesses. Solid momentum across Android, Google Pay and Waymo are likely to have been a tailwind.
Here's Why You Should Invest in Water ETFs
by Neena Mishra
Water sustainability is a growing concern for many investors
Waters (WAT) Boosts Thermal Analysis With Latest Software
by Zacks Equity Research
Waters (WAT) strengthens the product portfolio by introducing TRIOS AutoPilot software for the thermal analyzer product line.
Agilent (A) Expands Presence in LC Market With New Systems
by Zacks Equity Research
Agilent (A) expands its Bio Liquid Chromatography solutions portfolio with three new systems to fulfil the needs of biopharma industry.
Waters (WAT) Expands Reach to Scientists Via Latest Launch
by Zacks Equity Research
Waters (WAT) expands the product portfolio by introducing Arc Premier System for chromatographic separations.
Why Is Waters (WAT) Up 2.4% Since Last Earnings Report?
by Zacks Equity Research
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Waters (WAT) Q1 Earnings Beat Estimates, Revenues Rise Y/Y
by Shilpa Mete
Waters' (WAT) first-quarter results reflect gains from strong momentum across Asia, the Americas and Europe, and robust performance in the pharmaceutical and industrial markets.